US-China biopharma firm ShouTi mops up $100m from LAV, Qiming, others

US-China biopharma firm ShouTi mops up $100m from LAV, Qiming, others

Clinical-stage biopharmaceutical company ShouTi Inc has mopped up as much as $100 million in its Series B round of financing led by BVF Partners, a San Francisco-based private investment firm.